Search

everythinglearnresearchcommunity

for

Search:↓

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

The book is recommended for its new scientific information and balanced treatment options for hair loss in domestic animals.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Fluconazole is an effective antifungal medication with potential side effects and lacks official analytical methods for its determination.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Skin diseases are very common in poor areas, and there's a need for affordable ways to manage and improve skin health.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

WAA-QOL measures impact of hair loss on women's well-being.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Optimized film improves finasteride skin absorption and treatment efficiency.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.